Previous 10 |
Las Vegas, Nevada, Nov. 27, 2018 (GLOBE NEWSWIRE) -- International Membership Data, LLC will receive $40 Million in investment from Protect Pharmaceutical Corporation. (PRTT), an OTC publicly traded company that will accelerate the adoption of IMD’s three blockchains and launches the...
LAS VEGAS, Oct. 20, 2018 (GLOBE NEWSWIRE) -- Protect Pharmaceuticals Corporation (OTC: PRTT), a Nevada Corporation, acquired Las Vegas based Tobit LLC’s business model Tobit Clicks ( https://tobitclicks.com/ ) and 80 % of it’s ERC -20 Tokens (8,000,000 Tobits). PRTT also acq...
LAS VEGAS, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Protect Pharmaceuticals Corporation (OTC: PRTT), a Nevada Corporation, officially announces that it has become a Founding Member of the Tobit Consortium. Protect Pharmaceutical announced in September that it along with several other businesses...
LAS VEGAS, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Protect Pharmaceuticals Corporation (OTC: PRTT), a Nevada Corporation, officially announces the launch of a new business model. Protect Pharmaceutical along with a consortium of businesses have entered into an agreement that will result in th...
News, Short Squeeze, Breakout and More Instantly...
Protect Pharmaceutical Company Name:
PRTT Stock Symbol:
OTCMKTS Market:
Protect Pharmaceutical Website:
ANKARA, Turkey, July 01, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: "July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the ...
ISTANBUL, Turkey, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) President, Ali Yildiz, publishes his February 2024 corporate update letter to Company Shareholders as follows: "February 5, 2024 Dear Shareholders: Management announces that it has finaliz...
ISTANBUL, Turkey, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.’s (OTC: PRTT) President, Ali Yildiz, publishes a letter to Company Shareholders as follows: “Dear Shareholders of Protect Pharmaceutical Corp.: We have continued working with respect to finali...